Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DCC-3084 by Deciphera Pharmaceuticals for Lung Cancer: Likelihood of Approval
DCC-3084 is under clinical development by Deciphera Pharmaceuticals and currently in Phase II for Lung Cancer. According to GlobalData, Phase...
DCC-3084 by Deciphera Pharmaceuticals for Melanoma: Likelihood of Approval
DCC-3084 is under clinical development by Deciphera Pharmaceuticals and currently in Phase II for Melanoma. According to GlobalData, Phase II...
DCC-3084 by Deciphera Pharmaceuticals for Pancreatic Cancer: Likelihood of Approval
DCC-3084 is under clinical development by Deciphera Pharmaceuticals and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...